Marcovich, M.D., RobertSchool of Medicine |
|
|
I am a Urologist with subspecialty training in minimally invasive surgery and treatment of kidney stones. I provide both surgical therapy for urinary tract stones and medical evaluation and treatment to prevent future stone formation in at-risk patients. I am one of the few urologists in the country who is able to gain percutaneous access to the kidney for stone removal without the assistance of an interventional radiologist. |
|
| 7/2003 - Present | Assistant Professor | University of Texas Health Science Center at San Antonio, Surgery, San Antonio, TX |
| Year | Degree | Discipline | Institution |
| 2003 | Clinical Fellowship | Endourology & Laparoscopy | Long Island Jewish Med. Ctr /Albert Einstein College of Med New Hyde Park , NY |
| 2002 | Postdoctoral Fellowship | Endourology | Long Island Jewish Medical Center/Albert Einstein College of Medicine New Hyde Park , NY |
| 2001 | Residency | Urology | University of Michigan Ann Arbor , MI |
| 1996 | Internship | General Surgery | University of Michigan Ann Arbor , MI |
| 1995 | MD | Medicine | Brown University Providence , RI |
| 1991 | BS | Biology (Honors) | Brown University Providence , RI |
Endourology- Minimally invasive endoscopic surgical therapy for a variety of urologic disorders including: Laser ablation of kidney, ureteral, and bladder stones; Endoscopic management of kidney and ureteral cancer (transitional cancer); Endoscopic management of ureteral and intrarenal strictures (blockages); Endoscopic laser ablation of enlarged prostate gland; Extracorporeal shockwave lithotripsy for kidney and ureteral stones; |
Laparoscopy |
| Date | Description | Institution | # Students |
| 1/2007 - Present | Pre-Doctoral Student Supervision | Department of Urology, UTHSCSA | |
| 9/2006 - Present | Adv Clin Eval Skills | The University of Texas Health Science Center | |
| Third year medical students recieve a lecture and watch a video of an acutal male urologic physical eaxm. The students are then instructed with volunteer patients on the proper procedure for a Digital Rectal Exam. | |||
| 7/2003 - Present | Urology Selective | The University of Texas Health Science Center | |
| 7/2003 - Present | Medical Student Lectures | UTHSCSA | 200 students |
| I do a 1 hour lecture on urolithiasis pathophysiology, diagnosis, and clinical management for the 2nd year medical students during the Urology pathophysiology lecture block. This lecture is updated every year. | |||
| 7/2003 - Present | Urology Journal Club | UTHSCSA | 10 students |
| This is a monthly 90-minute seminar in which recent significant scientific articles in the urologic literature are presented and analyzed. | |||
| 7/2003 - Present | Post-Doctoral Student Supervision | Univeristy Hospital | |
| 7/2003 - Present | Post-Doctoral Student Supervision | Santa Rosa Medical Center Tower 2 | |
Journal Article |
| Rastinehad, A Marcovich, M.D. R Ost, M VanderBrink, B Greenberg, K El-Hakim, A Badlani, G Smith, A.D. A 20 Year Experience of Percutaneous Resection of Upper Tract Urology 2009 Jan;73(1):27-31. |
| Reed A, SURI R, Marcovich R. Passage of embolization coil through urinary collecting system one year after embolization Urology 2007 Dec;70(6):1222-e.17-8. |
| French DB, Marcovich R. Fibrin sealant for retrograde ureteroscopic closure of urine leak after partial nephrectomy Urology, In press 2006 May;67:1085e1-1085e3. |
| French DB Marcovich R. Fibrin sealant for retrograde ureteroscopic closure of urine leak after partial nephrectomy Urology 2006 May;67(5):1085e1-1085e3. |
| El-Hakim A, Marcovich R, Chiu KY, Lee BR, Smith AD. First prize: ureteral segmental replacement revisited J Endourol 2005 Nov;19(9):1069-1074. |
| Marcovich R, Smith AD. Percutaneous renal access: tips and tricks BJU Int 2005 Mar;95:78-84. |
| Tan BJ, Rastinehad AR, Marcovich R, Smith AD, Lee BR. Trends in ureteropelvic junction obstruction management among urologists in the United States Urology 2005 Feb;65(2):260-264. |
| Marcovich R, Jacobson Al, Singh J, Shah D. No panacea for drainage after percutaneous nephrolithotomy J Endourol 2004 Oct;18:743-747. |
| El-Hakim A, Cai Y, Marcovich R, Pinto P, Lee BR. Effect of Endo-GIA vascular staple size on laparoscopic vessel sealing in a porcine model Surg Endosc 2004 Apr;. |
| Lee BR, Marcovich R, Chiu KY, Smith AD. The laparoscopic Monti procedure for long strictures of the proximal ureter: a novel technique BJU Int 2004 Mar;93(4):631-633. |
| Chiu KY, Cai Y, Marcovich R, Smith AD, Lee BR. Are new-generation flexible ureteroscopes better than their predecessors? BJU Int 2004 Jan;93(1):115-119. |
| Marcovich R. Approaches to tissue engineering in the urinary tract Curr Med Lit Urol 2004 Jan;10:61-65. |
Book Chapter |
| Tan BJ, Ost MC, Marcovich R, Lee BR, and Smith AD. Percutaneous Approach to Transitional Cell Carcinoma of the Upper Urinary Tract. In: Naito, S.; Hirao, Y.; Terachi, T. (Eds.). Endourological Management of Urogenital Carcinoma. 2006. |
Abstract |
| Allam C Soderdahl D Hernandez J Marcovich R. Multi-institutional experience of a composite metallic ureteral stent for the treatment of external ureteral commpression; 2009 Jan. (James C. Kimbrough Urological Seminar Abstract Book). |
| Fukuda, R. Marcovich, M.D. R. Impact of selective treatment parameters on practice patterns of intrarenal calculi; 2008 Jan. (Journal of Endourology). |
| Marcovich R Fukuda R. EFFICACY OF NON-CONTACT HOLMIUM:YAG LITHOTRIPSY IN AN IN VITRO MODEL; 2007 Oct. (Journal of Endourology. October 1, 2007, 21(supplement 1): A1-A292. doi:10.1089/end.2007.WCE03; vol. 21, no. Supp1). |
| Fukuda R, Marcovich R. Metabolic risk factors for nephrolithiasis in hispanics versus whites in the United States; 2006 Aug. (Journal of Endourology; vol. 20, no. Supp1). |
| Stallman KJ, Marcovich R, Glickman RD, Teichman JM. Holmium: YAG lithotripsy fiber performance as a function of chemical environment; 2005 Jul. (J Endourol; vol. 19, no. Sup1). |
| Stallman KJ, Marcovich R, Glickman RD, Teichman JMH. Holmium: YAG lithotripsy fiber performance as a function of chemical environment; 2005 Jul. (Journal of Endourology; vol. 19, no. Supp1). |
| Fenton AS, Kraus SR, Marcovich R. Endourologic management of focal ileovesicostomy stenosis. Abstract MP 26/14; 2004 Nov. (J Endourol; vol. 18, no. Supp1). |
| Tan B, Rastinehad A, Lee Br, Smith AD, Marcovich R. Trends in the management of ureteropelvic junction obstruction among urologists in the United States-An internet survey. Abstract MP 3/5; 2004 Nov. (J Endourol; vol. 18, no. Supp1). |
| Marcovich R., A. Rastinehad, A. El-Hakim, Smith AD, et al. Medical Malpractice Trends in Contemporary Urological Laparoscopy: Results of an Internet Survey. Abstract 476; 2004 Jan. (J Urol; vol. 171, no. 4Supp). |
| El-Hakim A, Chertin B, Marcovich R, Lee BR, et al. Adjuvant bacillus Calmette-Guerin therapy after endoscopic treatment of upper tract transitional cell carcinoma: first proof of efficacy. Abstract 1760; 2004 Jan. (J Urol; vol. 171, no. 4 Sup). |
| Marcovich R, Atala A., Chiu KY, El-Hakim, et al. Ureteral Segmental Replacement Revisited. Abstract 19; 2004 Jan. (J Urol; vol. 171, no. 4Supp). |
| Marcovich R, Chiu KY, El-Hakim A, et al. Segmental Ureteral Replacement Revisited. Abstract BR 2/8; 2004 Jan. (J Endourol; vol. 18, no. Supp1). |
Review Article |
| Ryan F. Paterson, M.D., Tadashi Matsuda, M.D., Robert Marcovich, M.D., Anup Patel, M.D., Hans-Gran Tiselius, M.D., Ph.D., Francis X. Keeley, Jr., M.D., Maurice S. Michel, M.D., Ph.D., and David I. Lee, M.D. Survey of Endourology February 2008 - Percutaneous Surgery Journal of Endourology 2008 Feb;22(2):231-242. |
| Marcovich R. Survey of Endourology August 2007 - Percutaneous Surgery Journal of Endourology 2007 Aug;21(8):849-851. |
| Van Cangh P. Smith AD. NG CS. Ost MC. Marcovich R. Wong M. Joyce AD. Desai RA. Assimos DG. Management of difficult kidney stones Journal of Endourology 2007 May;21(5):478-489. |
| Marcovich R. Survey of Endourology February 2007 - Percutaneous Surgery Journal of Endourology 2007 Feb;21(2):127-128. |
Editorial |
| Marcovich R, Lee BR, Smith AD. Editorial Comment Urology 2004 Jul;64(1). |
Federal |
|
| Funding Agency | Southwest Oncology Group |
| Title | Evaluation of ZD 1839 (NSC#715055) for Advanced Transitional Cell Carcinoma of the Urothelium, Phase 2 (012-5011-052) |
| Status | Active |
| Period | - Present |
| Role | Co-Investigator |
| Grant Detail | |
| Funding Agency | Southwest Oncology Group |
| Title | The Effect of Fluoroquinolones on the Disease-Free Interval in Patients with Stage Ta Transitional Cell Carcinoma of the Bladder, Phase3(989-5011-383) |
| Status | Active |
| Period | - Present |
| Role | Co-Investigator |
| Grant Detail | |
| Funding Agency | Southwest Oncology Group |
| Title | Randomized Phase 3 Study Comparing Paclitaxel/Cisplatin/Gemcitabine and Cisplatin/Gemcitabine in Patients with Metastatic or Locally Advanced Urothelial Cancer Without Prior Systemic Therapy (012-5011-450) |
| Status | Active |
| Period | - Present |
| Role | Co-Investigator |
| Grant Detail | |
| Funding Agency | Southwest Oncology Group |
| Title | Intermittent Androgen Deprivation Patients with Stage D2 Prostate Cancer (945-5011-348) |
| Status | Active |
| Period | - Present |
| Role | Co-Investigator |
| Grant Detail | |
| Funding Agency | Southwest Oncology Group |
| Title | A Prospective Phase 3 Study Comparing Radical Surgery to Elective Kidney Sparing Surgery for Low Stage Renal Cell Cancer: An Interroup Study (990-5011-441) |
| Status | Active |
| Period | - Present |
| Role | Co-Investigator |
| Grant Detail | |
| Funding Agency | Southwest Oncology Group |
| Title | L-Selenium-Based Chemoprevention of Prostate Cancer Among Men with High Grade Prostatic Intraepithelial Neoplasia (990-5011-277) |
| Status | Active |
| Period | - Present |
| Role | Co-Investigator |
| Grant Detail | |
| Funding Agency | Southwest Oncology Group |
| Title | Central Prostate Cancer Repository Protocol (923-5011-092) |
| Status | Active |
| Period | - Present |
| Role | Co-Investigator |
| Grant Detail | |
| Funding Agency | Southwest Oncology |
| Title | Docetaxel and Estramustine Versus Mitoxantrone and Prednisone for Advanced, Hormone Refractory Prostate Cancer, Phase 3 (990-5011-170) |
| Status | Active |
| Period | - Present |
| Role | Co-Investigator |
| Grant Detail | |
| Funding Agency | Southwest Oncology Group |
| Title | Adjuvant Androgen Deprivation Versus Mitoxantrone Plus Prednisone Plus Androgen Deprivation in Selected High Risk Prostate Cancer Patients Following Radical Prostatectomy, Phase 3 (990-5011-172) |
| Status | Active |
| Period | - Present |
| Role | Co-Investigator |
| Grant Detail | |
| Funding Agency | Southwest Oncology Group, National Cancer Institute Canada |
| Title | Intergroup (NCIC, SWOG) Phase 3 Randomized Trial Comparing Intermittent Versus Continuous Androgen Suppression for Patients with Prostate-Specific-Antigen Progression in the Clinical Absence of Distant Metastases following Radiotherapy for Prostate Cance |
| Status | Active |
| Period | - Present |
| Role | Co-Investigator |
| Grant Detail | |
| Funding Agency | Southwest Oncology Group |
| Title | Protocol for Assessment of Gemcitabine and Paclitaxel for Metastatic Urothelial Cancer in patients Ages 70 Years or Older (And in a Cohort of Patients Younger than 60 Years) (012-5011-015) |
| Status | Active |
| Period | 12/2001 - Present |
| Role | Co-Investigator |
| Grant Detail | |
| Funding Agency | Southwest Oncology Group |
| Title | MVAC in Organ-Confined Bladder Cancer Based on p53 Status (012-5011-213) |
| Status | Active |
| Period | 4/2003 - Present |
| Role | Co-Investigator |
| Grant Detail | |
Private |
|
| Funding Agency | GSK |
| Title | A Randomized, Double-Blind, Parallel Group Study to Investigate the Efficacy and Safety of Treatment with Dutasteride (0.5mg) and Tamsulosin (0.4mg), Administered Once Daily for 4 Years, Alone and in Combination, on the Improvement of Symptoms and Clinic |
| Status | Active |
| Period | 8/2003 - Present |
| Role | Co-Investigator |
| Grant Detail | Closed to accrual 12/2004 |
| Funding Agency | Southwest Oncology Group |
| Title | Intergroup Phase 3 Randomized Trial Comparing Total Androgen Blockage versus Total Androgen Blockade plus Pelvic Irradiation in Clinical Stage T3-4, N0, M0 Adenocarcinoma of the Prostate (967-5011-109) |
| Status | Active |
| Period | - Present |
| Role | Co-Investigator |
| Grant Detail | |
| Funding Agency | Guilford Pharmaceuticals, Inc. |
| Title | Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 3 Arm, 12 Month Study to Evaluate the Effects of GPI 1485 on Erectile Function in Patients Undergoing Bilateral Nerve-Sparing Radical Retropubic Prostatectomy for Prostatic Carcinoma (0 |
| Status | Active |
| Period | 9/2003 - Present |
| Role | Co-Investigator |
| Grant Detail | Closed to accrual 03/2005 |